Phase I study of NK105, a nanomicellar paclitaxel formulation, administered on a weekly schedule in patients with solid tumors

Mukai, Hirofumi; Kato, Ken; Esaki, Taito; Ohsumi, Shouzou; Hozomi, Yasuo; Matsubara, Nobuaki; Hamaguchi, Tetsuya; Matsumura, Yasuhiro; Goda, Rika; Hirai, Takayuki; Nambu, Yoshihiro

期刊名称Investigational New Drugs
作者Mukai, Hirofumi; Kato, Ken; Esaki, Taito; Ohsumi, Shouzou; Hozomi, Yasuo; Matsubara, Nobuaki; Hamaguchi, Tetsuya; Matsumura, Yasuhiro; Goda, Rika; Hirai, Takayuki; Nambu, Yoshihiro
卷第34卷
期第6期
印刷ISSN0167-6997
电子ISSN1573-0646
文件大小533.14KB
发表时间2016-12
DOI10.1007/s10637-016-0381-4
页码750-759

发现好书期刊，享受阅读乐趣

Phase I study of NK105, a nanomicellar paclitaxel formulation, administered on a weekly schedule in patients with solid tumors